SCHEMBL7478792

SCHEMBL7478792

CC(C)(C)NC(=O)C(N)c1ccc(N)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
ALDH1A1 P00352 2/20 0.37
CNR2 P34972 2/20 0.36
CNR1 P21554 1/20 0.36
GRM8 O00222 1/20 0.35
GRM7 Q14831 1/20 0.35
GRM4 Q14833 1/20 0.35
MAPT P10636 2/20 0.34
RAB9A P51151 1/20 0.34
TXNRD1 Q16881 1/20 0.34
EPHX2 P34913 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33
RORA P35398 1/20 0.33
RORC P51449 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8006905 0.98 ADRB2 (0.39) ADRB2ADRB1ADRB3ALDH1A1CNR2
SCHEMBL996782 0.84 HDAC4 (0.44) ADRB2CNR2CNR1MAPT
SCHEMBL5572682 0.84 MAPT (0.49) ALDH1A1MAPTCYP2C9HIF1AKDM4E
SCHEMBL4984142 0.84 MAPT (0.49) ALDH1A1MAPTCYP2C9HIF1AKDM4E
SCHEMBL7039133 0.81 NPSR1 (0.50) ADRB3ALDH1A1GRM8GRM4MAPT
SCHEMBL8188747 0.75 CSK (0.45) ADRB2ADRB1ADRB3RAB9AEPHX2
SCHEMBL4872444 0.74 MAPT (0.41) ALDH1A1CNR2GRM8GRM7GRM4
SCHEMBL5573778 0.72 ROCK2 (0.46) ALDH1A1
SCHEMBL9620180 0.72 SLC6A3 (0.47) ADRB2ADRB1ADRB3ALDH1A1CNR2
SCHEMBL2357009 0.71 LMNA (0.37) ADRB2ADRB1ADRB3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211228-B1 COMPOUNDS WITH AMINO, GUANIDINO AND AMIDINO HETEROCYCLIC COMPOUNDS AXYS PHARMACEUTICALS, INC 2001-04-03 US disclosed
US-6022969-A Compositions and methods for treating mast-cell mediated conditions AXYS PHARMACEUTICALS, INC. (US) 2000-02-08 US disclosed
EP-0763016-B1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS AXYS PHARM INC (US) 2000-01-26 EP disclosed
US-5656660-A AMINE OR GUANIDINE GROUP-CONTAINING TRYPTASE INHIBITOR ARRIS PHARMACEUTICAL CORPORATION (US) 1997-08-12 US disclosed
EP-0782571-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL INFLAMMATORY CONDITION ARRIS PHARMACEUTICAL CORPORATION (US) 1997-07-09 EP disclosed
EP-0763016-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS ARRIS PHARMACEUTICAL CORPORATION (US) 1997-03-19 EP disclosed
WO-1996009297-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL INFLAMMATORY CONDITION ARRIS PHARMACEUTICAL CORPORATION (US) 1996-03-28 WO disclosed
WO-1995032945-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS ARRIS PHARMACEUTICAL CORPORATION (US) 1995-12-07 WO disclosed